sulfadiazine has been researched along with Erythrophagocytic Lymphohistiocytosis, Familial in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rioualen, S | 1 |
| Dufau, J | 1 |
| Flatres, C | 1 |
| Lavenant, P | 1 |
| Misery, L | 1 |
| Roué, JM | 1 |
1 other study available for sulfadiazine and Erythrophagocytic Lymphohistiocytosis, Familial
| Article | Year |
|---|---|
[DRESS complicated by hemophagocytic lymphohistiocytosis in an infant treated for congenital toxoplasmosis].
Topics: Antiprotozoal Agents; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Fatal Outcome; Hear | 2017 |